Simplex Trading
RIGL icon

Simplex Trading’s Rigel Pharmaceuticals RIGL Stock Holding History

Simplex Trading’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.8K Sell
2,500
-9,300
-79% -$287K ﹤0.01% 5570
2026
Q1 		$319K Buy
11,800
+7,500
+174% +$252K ﹤0.01% 3762
2025
Q4 		$184K Buy
4,300
+2,400
+126% +$90.5K ﹤0.01% 4313
2025
Q3 		$53K Buy
1,900
+900
+90% +$26.9K ﹤0.01% 6399
2025
Q2 		$18K Sell
1,000
-2,700
-73% -$51.2K ﹤0.01% 6869
2025
Q1 		$66K Sell
3,700
-4,100
-53% -$83.2K ﹤0.01% 5500
2024
Q4 		$131K Sell
7,800
-11,900
-60% -$228K ﹤0.01% 4930
2024
Q3 		$318K Sell
19,700
-13,400
-40% -$158K ﹤0.01% 4067
2024
Q2 		$272K Buy
33,100
+30,700
+1,279% +$321K ﹤0.01% 4335
2024
Q1 		$35K Sell
2,400
-10,180
-81% -$137K ﹤0.01% 6614
2023
Q4 		$182K Buy
12,580
+2,110
+20% +$21.6K ﹤0.01% 4772
2023
Q3 		$113K Sell
10,470
-2,390
-19% -$28.8K ﹤0.01% 4968
2023
Q2 		$165K Buy
12,860
+2,380
+23% +$32.2K ﹤0.01% 4524
2023
Q1 		$138K Sell
10,480
-1,420
-12% -$22.6K ﹤0.01% 4780
2022
Q4 		$178K Buy
11,900
+7,120
+149% +$65.3K ﹤0.01% 4359
2022
Q3 		$56K Sell
4,780
-2,920
-38% -$39.5K ﹤0.01% 6287
2022
Q2 		$87K Buy
7,700
+2,960
+62% +$59.4K ﹤0.01% 5761
2022
Q1 		$141K Sell
4,740
-530
-10% -$14.3K ﹤0.01% 5672
2021
Q4 		$139K Sell
5,270
-2,980
-36% -$89.9K ﹤0.01% 5718
2021
Q3 		$371K Buy
8,250
+80
+1% +$3.15K ﹤0.01% 4558
2021
Q2 		$354K Buy
8,170
+8,092
+10,374% +$306K ﹤0.01% 4704
2021
Q1 		$267K Buy
78
+26
+50% +$1.03K ﹤0.01% 4289
2020
Q4 		$180K Buy
52
+39
+300% +$1.13K ﹤0.01% 4756
2020
Q3 		$30K Buy
13
+12
+1,200% +$295 ﹤0.01% 6073
2020
Q2 		$1K Sell
1
-4
-80% -$72 ﹤0.01% 7399
2020
Q1 		$7K Sell
5
-1
-17% -$21 ﹤0.01% 6688
2019
Q4 		$12K Hold
6
– – ﹤0.01% 6295
2019
Q3 		$11K Buy
6
+3
+100% +$62 ﹤0.01% 6203
2019
Q2 		$8K Sell
3
-44
-94% -$993 ﹤0.01% 6237
2019
Q1 		$120K Buy
47
+45
+2,250% +$1.03K ﹤0.01% 4150
2018
Q4 		$5K Sell
2
-1
-33% -$28 ﹤0.01% 6234
2018
Q3 		$10K Sell
3
-5
-63% -$150 ﹤0.01% 6420
2018
Q2 		$22K Sell
8
-115
-93% -$4.09K ﹤0.01% 5800
2018
Q1 		$59K Buy
123
+119
+2,975% +$4.76K ﹤0.01% 2279
2017
Q4 		$4K Buy
+4
New +$152 ﹤0.01% 4733
2017
Q3 		– Sell
-4
Closed -$1K – 6510
2017
Q2 		$1K Sell
4
-26
-87% -$712 ﹤0.01% 5704
2017
Q1 		$18K Buy
+30
New +$764 ﹤0.01% 3362
2016
Q4 		– Sell
-28
Closed -$5K – 6408
2016
Q3 		$5K Buy
+28
New +$803 ﹤0.01% 4305
2016
Q2 		– Sell
-5
Closed -$2K – 6357
2016
Q1 		$2K Buy
+5
New +$123 ﹤0.01% 4789

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's RIGL Position: Q2 2026 in Review

Simplex Trading opened a new position in Rigel Pharmaceuticals (RIGL) in Q2 2026: 556 shares worth $21.8K. The stake represents ﹤0.01% of the portfolio and ranks #7032 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RIGL as recently as Q3 2025.

Simplex Trading first reported a position in RIGL in Q4 2014 and has held it in 27 quarters since. The position peaked at $323K in Q1 2021. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Simplex Trading held 556 shares of Rigel Pharmaceuticals worth $21.8K as of Q2 2026.
  • Rigel Pharmaceuticals was a new Simplex Trading position in Q2 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7032 holding.
  • Simplex Trading first reported a position in Rigel Pharmaceuticals in Q4 2014 and has held it in 27 quarters since.
  • Simplex Trading's Rigel Pharmaceuticals position peaked at $323K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.